ABBV vs MRK: AbbVie Inc. vs Merck & Co., Inc.
Side-by-side snapshot of two Healthcare companies — key metrics from our latest data. Reference only, not investment advice.
| Metric | ABBV | MRK |
|---|---|---|
| Company | AbbVie Inc. | Merck & Co., Inc. |
| Price | $256.46 | $150.33 |
| Market Cap | $453.19B | $370.89B |
| P/E Ratio | 72.45 | 120.26 |
| EPS | $3.54 | $1.25 |
| Dividend Yield | 2.70% | 2.23% |
| 52-Week High | $267.47 | $156.92 |
| 52-Week Low | $190.75 | $77.58 |
| Beta | 0.28 | 0.23 |
| Return on Equity (ROE) | — | 6.96% |
| Debt-to-Equity | — | 128.41% |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Exchange | NYQ | NYQ |
| Employees | 57,000 | 73,000 |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →A dedicated finance calculator for TVM, NPV and rate-of-return work.
Check Price →JL Collins' plain-English guide to index investing and financial independence.
Check Price →AbbVie Inc. and Merck & Co., Inc. both operate in the Healthcare sector. ABBV has a market cap of $453.19B versus MRK's $370.89B. On valuation, ABBV carries a trailing P/E of 72.45 against 120.26 for MRK. In terms of earnings, ABBV posts EPS of $3.54 versus MRK's $1.25. For price range, ABBV has traded between $190.75 and $267.47 over the past 52 weeks, and MRK between $77.58 and $156.92. On income, ABBV yields 2.70% versus MRK's 2.23%. On volatility, ABBV carries the higher beta (ABBV 0.28 vs MRK 0.23), meaning it has historically moved more sharply than the market. How these figures compare depends on each company's growth profile, margins and competitive position — this snapshot is a starting point for research, not a recommendation.
Comparing two companies becomes much more powerful once you can read their financials directly — financial statement analysis guides are a practical next step. Many investors track comparisons like this in a dedicated stock research journal.
Figures are from our latest data snapshot and may not reflect current market prices. See the full profiles: AbbVie Inc. and Merck & Co., Inc.. This is not financial advice.
Recommended Reading
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →A desk whiteboard for tracking tickers, levels and ideas at a glance.
Check Price →Robert Kiyosaki's bestseller on assets, liabilities and financial literacy.
Check Price →